| Stage | LXFR | % of rev | LIN | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $92M | 100.00% | $9.4B | 100.00% | LIN ×102.55 |
| Gross profit | $22M | 24.43% | $4.4B | 47.24% | LIN +22.8pp |
| Operating income | $3M | 3.05% | $2.1B | 22.86% | LIN +19.8pp |
| Pre-tax income | $2M | 1.85% | $2.1B | 22.63% | LIN +20.8pp |
| Net income | $900,000 | 0.98% | $1.7B | 18.50% | LIN +17.5pp |
| Stage | LXFR | LIN | Gap · A − B |
|---|---|---|---|
| Revenue | $92M100.00% | $9.4B100.00% | LIN ×102.55 |
| Gross profit | 24.43%$22M | 47.24%$4.4B | LIN +22.8pp |
| Operating income | 3.05%$3M | 22.86%$2.1B | LIN +19.8pp |
| Pre-tax income | 1.85%$2M | 22.63%$2.1B | LIN +20.8pp |
| Net income |
| 0.98%$900,000 |
| 18.50%$1.7B |
| LIN +17.5pp |
No shared counterparties.